Bio
Dr. Cheng is a non-invasive cardiologist specializing in cardio-oncology and a Clinical Assistant Professor in the Department of Medicine, Division of Cardiovascular Medicine, at Stanford University School of Medicine. She completed her fellowship in Cardiovascular Medicine at Stanford University.
In addition to providing care for general cardiovascular diseases, Dr. Cheng’s clinical practice focuses on the cardiovascular care of cancer patients and survivors. She provides comprehensive, evidence-based cardiovascular care before, during, and after cancer treatment, with expertise in managing acute cardiotoxicities from cancer therapies and supporting the long-term heart health of cancer survivors.
Her research is dedicated to advancing care delivery for cardio-oncology patients. She is particularly interested in the risk assessment and management of cardiotoxicity related to cancer therapies. Her work has been supported by an NIH F32 award, which funded her investigation into myocarditis associated with immune checkpoint inhibitors.
In addition to her clinical and research work, Dr. Cheng is committed to education, mentorship, and advocacy. She previously served as Co-Chair of the Fellows-in-Training Committee for the California Chapter of the American College of Cardiology. Drawing on her background in health policy in Washington, D.C., she continues to advocate for equitable access to high-quality cardiovascular care.
